China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price...
NHSA (prev. SMIA)
China’s 2023 NRDL Expands Coverage with 126 New Drugs, Aims for Savings and Accessibility
The National Healthcare Security Administration (NHSA) has released the finalized National Reimbursement Drug List (NRDL)...
China’s NHSA Issues Guidelines to Strengthen Medical Pricing and Procurement Credit Ratings
The National Healthcare Security Administration (NHSA) has issued a notification concerning medical pricing and tendering...
NHSA Completes Expert Review for National Reimbursement Drug List Updates
The National Healthcare Security Administration (NHSA) has announced the completion of the expert review stage...
NHSA Issues Guidelines to Strengthen Medical Insurance Payment Management
The National Healthcare Security Administration (NHSA) has released a set of guiding opinions aimed at...
EU Chamber of Commerce in China Releases Position Paper, Addresses Pharma and Healthcare
The EU Chamber of Commerce in China has released its bi-annual “European Business in China...
NHSA Clears Retagliptin and Ambroxol for National Reimbursement Drug List Inclusion
The National Healthcare Security Administration (NHSA) has completed a review of the National Reimbursement Drug...
NHSA Unveils Measures to Enhance Smart Monitoring and Auditing of Basic Medical Insurance Funds
The National Healthcare Security Administration (NHSA) has released a notification detailing planned measures to improve...
NHSA Mandates National Standards for Medical Consumables in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification with a focus on enhancing...
China Releases Third List of Pediatric Drugs to Guide Development and Filings
The National Health Commission (NHC), National Healthcare Security Administration, National Medical Products Administration (NMPA), and...
NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has released a notification disclosing the drugs that have...
National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector
An anti-corruption crackdown announced by the National Health Commission (NHC) at the end of July...
NHSA Issues 2023 Guidelines: Enhancing Basic Medical Insurance and Major Illness Coverage
The National Healthcare Security Administration (NHSA) has released the “Notice on Ensuring Basic Healthcare Security...
NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update
The National Healthcare Security Administration (NHSA) has officially released the “Negotiation Drug Renewals” and “Non-exclusive...
National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector
The emergency response department of the National Health Commission (NHC) has released a notification signaling...
NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh
The National Healthcare Security Administration (NHSA) has released its 2023 Basic Medical Insurance (BMI) Fund...
NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%
The National Healthcare Security Administration (NHSA) has released its annual statistical report for 2022, detailing...
NHSA Unveils Updated National Reimbursement Drug List Rules for 2023
The National Healthcare Security Administration (NHSA) has released the updated rules that will govern this...
NHSA Unveils 2023 Work Plan for National Reimbursement Drug List Update
The National Healthcare Security Administration (NHSA) has released the “Work Plan for the National Reimbursement...
NHSA Report Highlights ‘Flying Inspections’ Impact on Medical Insurance Fund Use in 2022
The National Healthcare Security Administration (NHSA) has released a report outlining the outcomes of ‘flying...